🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 12 of 78

  1. US 11207339

    Targeted cancer therapy

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11207315

    Emetine compounds for treatment and prevention of flavivirus infection

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11202824

    Peptide fragments from filoviruses and their uses

    Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11197879

    Flavonoid compositions and uses thereof

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11191824

    Method of purifying virus-like-particles

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11191821

    Peptide vaccine formulations and use thereof for inducing an immune response

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11191727

    Multivalent nanoparticle-based vaccines

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11192903

    Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11191763

    HIV post-exposure prophylaxis

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11185581

    Human rotavirus G9P[6] strain and use as a vaccine

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11186622

    PAC1 receptor agonists (MAXCAPS) and uses thereof

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11180751

    CRISPR enzymes and systems

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11174292

    Substitutions-modified prefusion RSV F proteins and their use

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11173150

    Method for diagnosing, preventing, and treating neurological diseases

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11173201

    Methods and compositions for inducing protective immunity against filovirus infection

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11167025

    Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11167012

    Peptide inhibition of CCR3-mediated diseases or conditions

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11160859

    Materials and methods for respiratory disease control in canines

    Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11160826

    Cholesterol lowering drugs for the treatment of hepatic encephalopathy

    Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11154519

    Inhibitors and their uses

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11154574

    Tumor infiltrating lymphocytes and methods of therapy

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11155834

    Sin Nombre virus full-length M segment-based DNA vaccines

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11154608

    Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11149082

    Multispecific antibodies targeting human immunodeficiency virus and methods of using the same

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11147837

    Modified cells and methods of therapy

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11147867

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11141398

    Methods for decreasing injuries associated with intraoperative hypotension

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11141393

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11136372

    ApoC-II mimetic peptides

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11136356

    Recombinant HIV-1 envelope proteins and their use

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11129835

    Methods and compositions for the inhibition of PIN1

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11130785

    Prefusion RSV F proteins and their use

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11129808

    PKC-delta-I inhibitor formulations and uses thereof

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11116740

    Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11116830

    Bacterial polysaccharide-conjugated carrier proteins and use thereof

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11110181

    Virus-like particle conjugates for diagnosis and treatment of tumors

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11111306

    IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11110150

    Complexes of IL-15 and IL-15Ralpha and uses thereof

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11110183

    Method of delivering genes and drugs to a posterior segment of an eye

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11110089

    Pyridazinones and their use in the treatment of cancer

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11111478

    Methods of producing T memory stem cell populations

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11103528

    Slow release calcium composition

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11103572

    Thermal inactivation of rotavirus

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11098054

    Englerin derivatives for treatment of cancer

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11098283

    T cells modified to overexpress c-Myb

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11098084

    Virus-like particles and methods of use

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11096927

    Anti-flavivirus compounds and methods of use

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11098053

    Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.